XPX-67009-60615 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Registered in v-safe
2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-21
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Good · Site: Pain

Free text: Mild light headedness, most noticeably within the first hour of vaccine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Survey response — days 1–6 daily, dose 1
MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Muscle or body aches

Free text: Only on injected arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-11
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-18
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-18
Report sent to call center — day 7, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Survey response — day 21, dose 2
MedDRA: Palpitations — Feeling: Good

Free text: Heart palpitations

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Survey response — day 28, dose 2
MedDRA: Dyspnoea, Palpitations — Feeling: Good · Be unable to do your normal daily activities

Free text: Intermittent Heart palpitations and SOB.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-13
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnant. COVID-19

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-18	priority 2/3
2022-01-13	Unsuccessful

Free text

Release 1 — day 0, dose 1

2020-12-21

Systemic reaction (other): Mild light headedness, most noticeably within the first hour of vaccine

Release 1 — days 1–6 daily, dose 1

2020-12-22

Systemic reaction (other): Only on injected arm

Release 3 — day 21, dose 2

2021-02-01

Symptoms: Heart palpitations

Release 3 — day 28, dose 2

2021-02-08

Symptoms: Intermittent Heart palpitations and SOB.

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Pregnant. COVID-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Dyspnoea	✓	✓	✓
SD	Palpitations	✓	✓	✓
SD	Pregnancy	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release